Abstract: Based on SPTS Pegasus Bosch-licensed deep reactive-ion silicon etching system, an advanced two-step etching process has been developed for hollow microneedles for transdermal blood sampling and drug delivery application. Assisted with a bi-layer mask, separated hollow etch and cavity etch steps have successfully achieved both the narrow microneedle bores and the cavity etch with large open etch load area for creating the near-vertical sidewall of the microneedle structures. Results show that the etch rate of silicon during this hollow etch step was about 7.5 µm/min and the etch rate of silicon during this cavity etch step was about 8 to 10 µm/min. The microneedle bores have successfully been etched 50~150 μm in inner diameter and 700~1000 μm deep with high aspect ratio DRIE, meanwhile, the vertical sidewall structures have been achieved with the high etch load exposed area over 70% for the cavity etch step.
Introduction
For point of care applications, blood sampling, diagnostic / monitoring, and controlled release of therapeutic agents into the body could be achieved through transdermal sampling / injection via an array of microneedles or using an implantable drug delivery system integrated with a diagnostic monitoring sensor [1] [2] [3] . Microneedles in length of 1mm have been developed for both transdermal blood sampling and drug delivery applications. A schematic of hollow structured microneedles for these applications is shown in Fig. 1 . Using microneedle delivery avoids implanting a device inside the body and its associated regulatory issues. Based on Micro Electro Mechanical Systems (MEMS) technology, microneedles can be fabricated as thousands of microscale features on a single silicon wafer that can then be diced into hundreds of "biochips" [4] [5] [6] . Ultimately, in drug delivery application, a continuous supply of a therapeutic drug would be required. The microneedle arrays would thus need to be integrated with a microfluidic pump, such as a voltage controlled pump developed previously [7] .
SPTS Pegasus System
SPTS Technologies is a leading established manufacturer of etch, deposition, and thermal processing equipment for the semiconductor and related industries, with >900 process modules produced. SPTS shipped its first Bosch-licensed deep reactive-ion etching (DRIE) system in 1995 and currently received an order for its 900th DRIE process module in September 2011. DRIE is a highly anisotropic etch process used to create structures in silicon, and is the cornerstone of modern MEMS production. The DRIE process, also known as the Bosch Process, is multi-step plasma etch process used to etch anisotropic features in silicon, consisting of a cyclic process employing 3 stages: (1) deposition of CF x layer (2) removal of deposition (3) etching of Si. The CF x deposition minimises lateral etching of the sidewalls, thus achieving anisotropic profiles. The silicon is etched chemically by F radicals, obtained from fragmentation of SF 6 molecules. DRIE is a key enabling process used in the manufacture of many silicon-based MEMS devices, and has expanded to applications for power devices (in deep trench isolation) and through-silicon-via (TSV) in advanced 3D-IC production [8, 9] . The SPTS Pegasus Si etch module has been used to perform the DRIE steps for microneedle fabrication. This module has a decoupled plasma source, capable of high etch rates (>30 m/min), low sidewall roughness (<20 nm), and uniform etch depth control for wafer sizes up to 200 mm. For maximum etch rates, high flow rates with accompanying high source powers and pressures are required. Typically, the ion densities produced under such conditions, lead to excessive mask etchrates and sidewall damage. Such effects, in turn limit the etch depths that can be achieved. The SPTS Pegasus plasma source is designed to deliver a high radical flux, with minimal ion flux, at the wafer level. Plasma generation takes place in a small volume compared to the wafer chamber downstream, resulting in high radical concentrations for typical source powers of 2.5 -4.5 kW. The source is designed to achieve high ion loss to the source walls, and electro-magnets are also used to control ion density levels. Fast switching on-board mass flow controllers also allow low sidewall roughness / scallops to be achieved at high rates. Fig. 2 shows a cross-section of the SPTS Pegasus plasma source.
Two-Step DRIE Process
Deep etching of high aspect ratio features is always challenging, especially for achieving the structures of narrow microneedle bores. It is different in the etch depth of features with varying areas of silicon. Areas with more open silicon etch faster compared to areas with lower amounts of open areas, such as in trenches and small width features, because of the ion flux loss at the bottom of a feature and the transport effects. Using the standard Bosch etch recipe with SPTS etch machine, current maximum aspect ratios of ~36:1 have been successfully obtained [10] [11] [12] .
Etching high load (>30% silicon area) wafers with good uniformity is also very challenging. There is a tendency for the centre of the wafer to etch more slowly than the edges, due to loading effects. Most decoupled plasmasources have a central plasma generation section and result in a centre-high radical profile distribution at the wafer level. Whilst this is desirable for high load applications, as pressure is increased for etch-rate enhancement, a centre-high etch uniformity characteristic starts to dominate. The SPTS Pegasus system has a unique annular plasma source arrangement. This allows operation at high pressure for high etch rates, whilst maintaining good uniformity control. Fig. 3 shows the standard modes of operation available on Pegasus. The results shown are for 100% loading 200mm blanket Si etches using SF 6 plasmas. Standard configuration changes can be used to deliver (a) centre high or and (b) centre low uniformity results, depending on the requirements. The figure also shows good etch uniformity maintained under high pressure conditions.
Conditions required for high aspect ratio via etching differ considerably from those required to etch large open structures. Performing both simultaneously would be detrimental to control and quality of the final structure. Assisted with a bi-layer mask, a novel two-step DRIE process has been developed successfully for the hollow microneedles fabrication, achieving both the narrow microneedle bores and the cavity etch with large open etch load area for creating the near-vertical sidewall of the microneedle structures.
Fabrication of Hollow Microneedles
Microneedles with 50~150 μm in inner diameter and 600~1000 μm long are the ideal solution for the transdermal blood sampling and drug delivery applications. It is suitable for low cost high volume based on the utilised high volume semiconductor manufacturing technologies, and could be integrated with nano-sensors and micro-fluidic devices for the point-of-care applications. The microneedles are much smaller than a traditional hypodermic needle and could be able to achieve the pain-free penetrating epidermis functions. Finite element method based simulations have been performed and the results show that the microneedle arrays would be mechanically stable under the mechanical stresses encountered during transdermal blood sampling and drug injection to penetrate the skin.
Using SPTS Pegasus system, the novel developed DRIE process is ideal for the hollow microneedle fabrication, which could achieve both the narrow microneedle bores and the vertical sidewall structures at one run without taking the wafer out from the process chamber. Assisted with a bi-layer mask, the hollow etch has been firstly achieved in STEP 1 to define 50 µm × 1000 µm narrow microneedle bores, and then the vertical sidewall structures were completed in STEP 2. In STEP 1, hollow etch, the power of the coil and the high frequency power sources were set as 2 kW / 36 W for the CF x deposition, and 2.2 kW / 36 W for the etching of silicon. It was shown that the etch rate of silicon during this hollow etch step was about 7.5 µm/min. In STEP 2, the cavity etch, to create the vertical sidewall structures of the microneedles, the power of the coil and the high frequency power were set as 2.6 kW / 0 W for the CF x deposition, and 2.8 kW / 60 W for the etching of silicon. The higher platen RF powers increased the ion directionality in high aspect ratio vias. It was shown that the etch rate of silicon during this hollow etch step was about 7.5 µm/min. It has been confirmed that the etch rate of silicon during this cavity etch step was about 8 to 10 µm/min. SEM Micrographs of the successfully fabricated hollow microneedles on a silicon wafer is shown in Fig. 4 . SEM pictures in Fig.  5 and 6 show that narrow microneedle bores have successfully been obtained 50~150 μm in inner diameter and 700~1000 μm long with high aspect ratio DRIE, meanwhile, the vertical sidewall structures have successfully been achieved with the high etch load exposed area over 70% for the cavity etch step.
Conclusions
SPTS Pegasus Bosch-licensed deep reactiveion silicon etching system has been used for fabricating hollow microneedles for transdermal blood sampling and drug delivery application. An advanced two-step etching process has been developed, assisted with a bilayer mask. Using the separated hollow etch and cavity etch steps, both the narrow microneedle bores and the cavity etch with large open etch load area have been achieved successfully. The near-vertical sidewall of the microneedle structures has been obtained as well. Results show that the etch rate of silicon were about 7.5 µm/min and about 8 to 10 µm/min during hollow etch and cavity etch steps, while the deeper it etched, the slower the etch rate was. The microneedle bores have successfully been fabricated with 50~150 μm in inner diameter and 700~1000 μm long, meanwhile, the vertical sidewall structures have been achieved with the high etch load exposed area over 70% for the cavity etch step. 
